LNSR LENSAR Inc
- Stocks
- Healthcare
- NASDAQ: LNSR
Price (delayed)
$12.52
Market cap
$149.42M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.22
Enterprise value
$144.61M
Relative Growth:
Rel. Growth:
48
Relative Strength:
Rel. Strength:
74
Relative Valuation:
Rel. Valuation:
19
Relative Profitability:
Rel. Profitability:
8
LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically
Highlights
LNSR's revenue is up by 29% year-on-year and by 2.3% since the previous quarter
LENSAR's gross profit has increased by 22% YoY
LENSAR's debt has increased by 15% YoY but it has decreased by 6% from the previous quarter
The equity has plunged by 197% YoY and by 4.1% from the previous quarter
LENSAR's quick ratio has shrunk by 57% YoY and by 29% QoQ
Key stats
What are the main financial stats of LNSR
Market
Valuations
Earnings
Shares outstanding
11.93M
Market cap
$149.42M
Enterprise value
$144.61M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
2.56
PEG
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.48
Revenue
$58.36M
Gross profit
$27.52M
Operating income
-$14.61M
Net income
-$49.31M
EBIT
-$49.31M
EBITDA
-$44.48M
Free cash flow
-$5.23M
Per share
Balance sheet
Liquidity
EPS
-$4.22
EPS diluted
-$4.22
Free cash flow per share
-$0.44
Book value per share
-$1.95
Revenue per share
$4.89
TBVPS
$5.43
Total assets
$70.41M
Total liabilities
$79.68M
Debt
$2.33M
Equity
-$23.05M
Working capital
$15.78M
Debt to equity
-0.1
Current ratio
1.52
Quick ratio
0.85
Net debt/EBITDA
0.11
Margins
Efficiency
Dividend
EBITDA margin
-76.2%
Gross margin
47.2%
Net margin
-84.5%
Operating margin
-25%
Return on assets
-72.6%
Return on equity
N/A
Return on invested capital
-164.8%
Return on capital employed
-122.3%
Return on sales
-84.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LNSR stock price
How has the LENSAR stock price performed over time
Intraday
2.96%
1 week
5.21%
1 month
2.71%
1 year
116.23%
YTD
40.04%
QTD
1.38%
Financial performance
How have LENSAR's revenue and profit performed over time
Revenue
$58.36M
Gross profit
$27.52M
Operating income
-$14.61M
Net income
-$49.31M
Gross margin
47.2%
Net margin
-84.5%
LNSR's revenue is up by 29% year-on-year and by 2.3% since the previous quarter
LENSAR's gross profit has increased by 22% YoY
LENSAR's net margin has increased by 15% from the previous quarter
LENSAR's operating margin has increased by 14% YoY but it has decreased by 5% from the previous quarter
Price vs fundamentals
How does LNSR's price correlate with its fundamentals
Growth
What is LENSAR's growth rate over time
Valuation
What is LENSAR stock price valuation
P/E
N/A
P/B
N/A
P/S
2.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.48
The EPS is up by 13% QoQ
The equity has plunged by 197% YoY and by 4.1% from the previous quarter
LNSR's P/S is 60% above its 5-year quarterly average of 1.6 and 16% above its last 4 quarters average of 2.2
LNSR's revenue is up by 29% year-on-year and by 2.3% since the previous quarter
Efficiency
How efficient is LENSAR business performance
The ROA has grown by 16% from the previous quarter
The ROS is up by 15% QoQ
The ROIC has increased by 7% QoQ
Dividends
What is LNSR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LNSR.
Financial health
How did LENSAR financials performed over time
The total assets is 12% less than the total liabilities
The current ratio has dropped by 61% year-on-year and by 16% since the previous quarter
LENSAR's quick ratio has shrunk by 57% YoY and by 29% QoQ
LENSAR's debt is 110% more than its equity
The equity has plunged by 197% YoY and by 4.1% from the previous quarter
LENSAR's debt has increased by 15% YoY but it has decreased by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.